All G

Based in Sydney, Australia, and founded in 2020 by CEO Jan Pacas, All G Co Holdings Pty Limited operates as an alternative protein company, providing a platform for creating dairy products and dairy proteins. In August 2026, All G raised an undisclosed amount of pre-series B funding from new investor Xeraya Capital, with participation from returning investors Agronomics Limited, Doehler Ventures, Ellerston Capital, ID Capital and Savencia Gourmet SA. All G provides plant-based and precision fermentation technologies to improve the consumption of alternative proteins. The company offers dairy proteins created by combining biology and big data from its foundational technology.

In addition, the company provides meat from plant-based alternatives, which are made from the identification and assembly of plant-based proteins in differentiated formats. All G Foods offers brands such as Milkcell and Love Buds for its customers that focus on health, sustainability, and animal welfare. All G generates revenue by producing and selling precision‑fermented bovine and human milk proteins, including lactoferrin, to infant formula, nutrition, and food manufacturers globally. The company will use the August 2026, funding to support production, regulatory filings, patent development, and expansion in Asia and Europe.